StockWatch
·
Specialty Chemicals
Clarification30 Sept 2026, 07:01 pm

Anupam Rasayan Clarifies Bliss GVS Pharma Share Acquisition

AI Summary

Anupam Rasayan India Ltd has issued a clarification regarding its earlier disclosure on the acquisition of equity shares of Bliss GVS Pharma Limited. The company has corrected typographical errors in the previous disclosure dated September 28, 2026. The acquirer, along with Persons Acting in Concert (PAC), has consummated the transaction under the Share Purchase Agreement (SPA). PAC has acquired 5,09,84,595 equity shares of Bliss, representing 47.95% of the total shares. Additionally, a previous mention of '1,699 equity shares' credited to the acquirer's demat account on August 24, 2026, has been corrected to '1,669 equity shares'. In total, the acquirer now holds 22,51,669 shares, and PAC holds 5,09,84,595 shares in Bliss GVS Pharma. All other details from the previous disclosure remain unchanged.

Key Highlights

  • Typographical errors in Bliss GVS Pharma share acquisition disclosure corrected.
  • PAC acquired 5,09,84,595 shares (47.95%) in Bliss GVS Pharma.
  • Acquirer's shareholding corrected to 22,51,669 shares.
  • Transaction consummated on September 28, 2026.
  • No other changes to the previous disclosure.